DaVita reports Q1 2026 revenue of $3.42B, net income of $198M, and continues share buybacks.

DaVita Inc. announced its financial results for Q1 2026, reporting consolidated revenues of $3.416 billion and net income attributable to the company of $198 million. The company achieved a diluted earnings per share of $2.87 and generated $321 million in operating cash flow. DaVita repurchased 3 million shares at an average price of $133.70 per share during the quarter and continues to focus on clinical excellence and operational rigor. The outlook for 2026 includes adjusted operating income guidance between $2.15 billion and $2.25 billion, with free cash flow expected between $1 billion and $1.25 billion. These results reflect steady treatment volume growth and ongoing investments in integrated kidney care and dialysis services.